prognosis of ulcerative colitis patients with reactivation of cytomegalovirus (CMV)

prognosis of ulcerative colitis patients with reactivation of cytomegalovirus (CMV) - The reactivation of cytogegalovirus in patients with ulcerative colitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009667

Enrollment

200

Registered

2012-12-30

Start date

2012-10-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 Definitive UC patients 2 Disease Activity Index is 6-12 points 3 Either inpatients or outerpatients 4 equal or more than 16 yeras-old

Exclusion criteria

Exclusion criteria: 1 patients have been entried to other clinical trial or clinical study 2 patients are planned to surgery

Design outcomes

Primary

Measure	Time frame
Remission rate in UC patients who are treataed and untreated with gancycrovir at 2 weeks after regstration of the study.	—

Countries

Japan

Contacts

Public ContactMakoto Naganuma

Keio University, School of Medicine Center for Diagnostic and Therapeutic Endoscopy

cmvproject.meeting@gmail.com81-3-3353-1211

Outcome results